{"key":"b7-33","slug":"b7-33","name":"B7-33","other_names":[],"kind":"single","area":{"slug":"other","name":"Other"},"classification":"Relaxin receptor agonist peptide","standing":{"id":"preclinical","label":"Animal and cell studies","rank":1},"summary":"A single-chain peptide derived from relaxin-2 that acts on the RXFP1 receptor, studied in animal models of fibrosis.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":15,"in_humans":10,"clinical_trials":0},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/b7-33","article":null,"evidence":{"query":"(\"B7-33\"[tiab])","fetched_at":"2026-11-16T22:51:56.191Z","counts":{"rcts":0,"human":10,"total":15,"reviews":1,"clinicalTrials":0},"years":[{"year":2012,"count":0},{"year":2013,"count":1},{"year":2014,"count":0},{"year":2015,"count":0},{"year":2016,"count":1},{"year":2017,"count":1},{"year":2018,"count":0},{"year":2019,"count":2},{"year":2020,"count":1},{"year":2021,"count":2},{"year":2022,"count":0},{"year":2023,"count":3},{"year":2024,"count":0},{"year":2025,"count":2},{"year":2026,"count":0}],"top":[{"doi":"10.3390/ijms241612670","url":"https://pubmed.ncbi.nlm.nih.gov/37628851/","kind":"study","pmid":"37628851","year":2023,"title":"Further Developments towards a Minimal Potent Derivative of Human Relaxin-2","venue":"International journal of molecular sciences","authors":"Handley TNG, Praveen P, Tailhades J, et al."},{"doi":"10.1016/j.mce.2019.01.008","url":"https://pubmed.ncbi.nlm.nih.gov/30641102/","kind":"review","pmid":"30641102","year":2019,"title":"Single chain peptide agonists of relaxin receptors","venue":"Molecular and cellular endocrinology","authors":"Praveen P, Kocan M, Valkovic A, et al."},{"doi":"10.1186/s12951-025-03833-w","url":"https://pubmed.ncbi.nlm.nih.gov/41430305/","kind":"study","pmid":"41430305","year":2025,"title":"Dual-functional nanovesicles simultaneously inhibit stromal fibrosis and angiogenesis to suppress cholangiocarcinoma progression","venue":"Journal of nanobiotechnology","authors":"Zhang L, Duan X, Shi Q, et al."},{"doi":"10.1021/acsami.9b17859","url":"https://pubmed.ncbi.nlm.nih.gov/31713411/","kind":"study","pmid":"31713411","year":2019,"title":"Coatings Releasing the Relaxin Peptide Analogue B7-33 Reduce Fibrotic Encapsulation","venue":"ACS applied materials & interfaces","authors":"Welch NG, Mukherjee S, Hossain MA, et al."},{"doi":"10.1016/j.ejphar.2017.05.005","url":"https://pubmed.ncbi.nlm.nih.gov/28478069/","kind":"study","pmid":"28478069","year":2017,"title":"B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)","venue":"European journal of pharmacology","authors":"Marshall SA, O'Sullivan K, Ng HH, et al."},{"doi":"10.1161/JAHA.119.015748","url":"https://pubmed.ncbi.nlm.nih.gov/32295457/","kind":"study","pmid":"32295457","year":2020,"title":"B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice","venue":"Journal of the American Heart Association","authors":"Devarakonda T, Mauro AG, Guzman G, et al."}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}